Abstract
Background:
The obesity paradox, which suggests that overweight and obesity exert protective effects on patient survival after acute myocardial infarction (AMI), is controversial in the existing researches.
Objective:
The aim of our study was to evaluate the associations of overweight and obesity with all-cause mortality in patients after AMI.
Methods:
The PubMed and Embase databases were searched for original articles published in English prior to March 2015, using the terms (‘myocardial infarction’ and (‘body mass index’ or BMI)) and (‘mortality’ or ‘death’). Prospective studies that reported the relationship between overweight and obesity at baseline (immediately after AMI) and all-cause mortality outcomes were eligible. Two authors separately performed the extraction of the data, and any differences were discussed and resolved. Pooled relative risks (RRs) and 95% confidence intervals (CIs) were computed either by fixed effects or random effects models.
Results:
Twenty studies were included in the present analysis. Comparing a healthy weight group to a combined overweight and obese group, the pooled RRs were 0.72 (95% CI: 0.57–0.90) for in-hospital mortality, 0.39 (95% CI: 0.28–0.55) for short-term mortality, 0.66 (95% CI: 0.55–0.78) for medium-term mortality and 0.68 (95% CI: 0.57–0.81) for long-term mortality. However, the RRs were 0.82 (95% CI: 0.64–1.06) for in-hospital mortality and 0.94 (95% CI: 0.55–1.58) for short-term, 0.82 (95% CI: 0.65–1.04) for medium-term and 0.98 (95% CI: 0.88–1.09) for long-term mortality when the obese group was compared with the overweight group, which were not significant.
Conclusions:
This meta-analysis identified an inverse association between overweight and obesity with all-cause mortality after AMI compared with healthy weight, which indicated an obesity paradox. Another notable finding is that obesity is associated with neither an increased nor a decreased risk of death in patients after AMI compared with overweight patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
World Health Organization. Obesity and overweight. Available at http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed 22 March 2015).
Hubert HB, Feinleib M, McNamara PM, Castelli WP . Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968–977.
Gelber RP, Gaziano JM, Manson JE, Buring JE, Sesso HD . A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens 2007; 20: 370–377.
Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305–313.
Korantzopoulos P, Kolettis TM . Obesity and the risk of new-onset atrial fibrillation. JAMA 2005; 293: 1974; author reply 1975.
Rabkin SW, Mathewson FA, Hsu PH . Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol 1977; 39: 452–458.
O'Brien EC, Fosbol EL, Peng SA, Alexander KP, Roe MT, Peterson ED . Association of body mass index and long-term outcomes in older patients with non-ST-segment-elevation myocardial infarction: results from the CRUSADE Registry. Circ Cardiovasc Qual Outcomes 2014; 7: 102–109.
Lazzeri C, Valente S, Chiostri M, Attana P, Picariello C, Sorini Dini C et al. Impact of age on the prognostic value of body mass index in ST-Elevation myocardial infarction. Nutr Metab Cardiovasc Dis 2013; 23: 205–211.
Gupta PP, Fonarow GC, Horwich TB . Obesity and the obesity paradox in heart failure. Can J Cardiol 2015; 31: 195–202.
Barba R, Marco J, Ruiz J, Canora J, Hinojosa J, Plaza S et al. The obesity paradox in stroke: impact on mortality and short-term readmission. J Stroke Cerebrovasc Dis 2015; 24: 766–770.
Park J, Ahmadi SF, Streja E, Molnar MZ, Flegal KM, Gillen D et al. Obesity paradox in end-stage kidney disease patients. Progr Cardiovasc Dis 2014; 56: 415–425.
Zeller M, Steg PG, Ravisy J, Lorgis L, Laurent Y, Sicard P et al. Relation between body mass index, waist circumference, and death after acute myocardial infarction. Circulation 2008; 118: 482–490.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008–2012.
Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. 2014. Available at http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed 22 March 2015).
Tomaszuk-Kazberuk A, Kozuch M, Malyszko J, Bachorzewska-Gajewska H, Kosacka U, Dobrzycki S et al. Do overweight patients have a better five years prognosis after an acute myocardial infarction treated with coronary intervention? Kardiol Polska 2012; 70: 686–693.
Nikolsky E, Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE et al. Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. Am Heart J 2006; 151: 168–175.
Aronson D, Nassar M, Goldberg T, Kapeliovich M, Hammerman H, Azzam ZS . The impact of body mass index on clinical outcomes after acute myocardial infarction. Int J Cardiol 2010; 145: 476–480.
Bucholz EM, Rathore SS, Reid KJ, Jones PG, Chan PS, Rich MW et al. Body mass index and mortality in acute myocardial infarction patients. Am J Med 2012; 125: 796–803.
Buettner HJ, Mueller C, Gick M, Ferenc M, Allgeier J, Comberg T et al. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J 2007; 28: 1694–1701.
Hoit BD, Gilpin EA, Maisel AA, Henning H, Carlisle J, Ross J Jr . Influence of obesity on morbidity and mortality after acute myocardial infarction. Am Heart J 1987; 114: 1334–1341.
Ikeda N, Nakajima R, Utsunomiya M, Hori M, Itaya H, Makino K et al. Higher body mass index at the time of acute myocardial infarction is associated with a favorable long-term prognosis (8-year follow-up). Heart Vessels 2011; 26: 495–501.
Kennedy LM, Dickstein K, Anker SD, Kristianson K, Willenheimer R . The prognostic importance of body mass index after complicated myocardial infarction. J Am Coll Cardiol 2005; 45: 156–158.
Kragelund C, Hassager C, Hildebrandt P, Torp-Pedersen C, Kober L . Impact of obesity on long-term prognosis following acute myocardial infarction. Int J Cardiol 2005; 98: 123–131.
Nigam A, Wright RS, Allison TG, Williams BA, Kopecky SL, Reeder GS et al. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol 2006; 110: 153–159.
Rana JS, Mukamal KJ, Morgan JP, Muller JE, Mittleman MA . Obesity and the risk of death after acute myocardial infarction. Am Heart J 2004; 147: 841–846.
Timoteo AT, Ramos R, Toste A, Oliveira JA, Patricio L, Ferreira ML et al. Impact of obesity on results after primary angioplasty in patients with ST segment elevation acute myocardial infarction. Rev Port Cardiol 2010; 29: 999–1008.
Wells B, Gentry M, Ruiz-Arango A, Dias J, Landolfo CK . Relation between body mass index and clinical outcome in acute myocardial infarction. Am J Cardiol 2006; 98: 474–477.
Wienbergen H, Gitt AK, Juenger C, Schiele R, Heer T, Towae F et al. Impact of the body mass index on occurrence and outcome of acute ST-elevation myocardial infarction. Clin Res Cardiol 2008; 97: 83–88.
Iozzo P, Rossi G, Michelassi C, Landi P, Carpeggiani C . Interpretation of the "obesity paradox": a 30-year study in patients with cardiovascular disease. Int J Cardiol 2013; 168: 112–116.
Kosuge M, Kimura K, Kojima S, Sakamoto T, Ishihara M, Asada Y et al. Impact of body mass index on in-hospital outcomes after percutaneous coronary intervention for ST segment elevation acute myocardial infarction. Circ J 2008; 72: 521–525.
Iakobishvili Z, Danicek V, Porter A, Assali AR, Battler A, Hasdai D . Is increased body mass index associated with a cardioprotective effect after ST-segment-elevation myocardial infarction? Acute Cardiac Care 2006; 8: 95–98.
Herrmann J, Gersh BJ, Goldfinger JZ, Witzenbichler B, Guagliumi G, Dudek D et al. Body mass index and acute and long-term outcomes after acute myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). Am J Cardiol 2014; 114: 9–16.
Suh JW, Mehran R, Claessen BE, Xu K, Baber U, Dangas G et al. Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol 2011; 58: 1750–1756.
Greenberg G, Assali A, Vaknin-Assa H, Brosh D, Teplitsky I, Fuchs S et al. Hematocrit level as a marker of outcome in ST-segment elevation myocardial infarction. Am J Cardiol 2010; 105: 435–440.
Lorgis L, Cottin Y, Danchin N, Mock L, Sicard P, Buffet P et al. Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction. Heart 2011; 97: 551–556.
Martinez-Rumayor A, Richards AM, Burnett JC, Januzzi JL Jr. . Biology of the natriuretic peptides. Am J Cardiol 2008; 101: 3–8.
Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002; 106: 2913–2918.
Taylor JA, Christenson RH, Rao K, Jorge M, Gottlieb SS . B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J 2006; 152: 1071–1076.
Dokainish H, Gonzalez R, Hartley WB, Caldera A, Koshy S, Sengupta R et al. Usefulness of B-type natriuretic peptide levels to predict left ventricular filling pressures in patients with body mass index >35, 31 to 35, and<or =30 kg/m2. Am J Cardiol 2007; 100: 1166–1171.
Abete P, Cacciatore F, Ferrara N, Calabrese C, de Santis D, Testa G et al. Body mass index and preinfarction angina in elderly patients with acute myocardial infarction. Am J Clin Nutr 2003; 78: 796–801.
Goldberg RJ, Cui J, Olendzki B, Spencer F, Yarzebski J, Lessard D et al. Excess body weight, clinical profile, management practices, and hospital prognosis in men and women after acute myocardial infarction. Am Heart J 2006; 151: 1297–1304.
Mehta L, Devlin W, McCullough PA, O'Neill WW, Skelding KA, Stone GW et al. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol 2007; 99: 906–910.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Author contributions
All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.
Supplementary Information accompanies this paper on International Journal of Obesity website
Rights and permissions
About this article
Cite this article
Wang, L., Liu, W., He, X. et al. Association of overweight and obesity with patient mortality after acute myocardial infarction: a meta-analysis of prospective studies. Int J Obes 40, 220–228 (2016). https://doi.org/10.1038/ijo.2015.176
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2015.176